Drug Channels Leadership Forum

The Drug Channels Leadership Forum returns for its third year at the JW Marriott Miami Turnberry Resort & Spa in Aventura, United States. This exclusive event is designed for senior leaders and decision-makers from various sectors of the drug channel ecosystem, including pharmaceutical manufacturers, PBMs, payers, specialty pharmacies, wholesalers, health systems, and solution providers. The forum emphasizes a curated atmosphere where discussions can focus on strategy, market direction, and leadership challenges without the distractions of traditional conferences that often include exhibit halls or press coverage. As an invitation-only gathering, the Drug Channels Leadership Forum ensures a peer-level audience conducive to candid, off-the-record dialogue.Attendees will have the opportunity to engage with some of the top leaders in the pharmaceutical industry, including Adam J. Fein, President of Drug Channels Institute, who is a well-regarded expert frequently quoted in major publications. The agenda promises high-level discussions and dynamic interactions, featuring industry leaders such as Debbie Weitzman, the CEO of Pharmaceutical & Specialty Solutions at Cardinal Health; Mostafa Kamal, President and CEO of Prime Therapeutics; Kevin Host, Senior Vice President of Pharmacy at Walmart; and Christine Marsh, Senior Vice President at Boehringer Ingelheim. Noteworthy sessions will be led by Dr. Fein, who will facilitate intimate fireside chats with thought leaders to delve into industry trends and challenges. This engaging salon-style format encourages open dialogue and a meaningful exchange of perspectives, enabling participants to tackle pressing issues facing pharmaceutical distribution channels. The event aims to provide attendees with actionable insights into drug pricing, reimbursement, market access, and specialty pharmacy strategies, ultimately enhancing their long-term decision-making processes in a rapidly evolving landscape.